Delivery Order SPE2DB22D9247-SPE2DB24FS2FJ

Award Date 7/24/24
Potential Completion Date 8/14/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,699.20 firm fixed-price delivery order is for the supply of 4,562,278,510 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31,...
This federal contract award, valued at $28,587.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a delivery order awarded under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
This federal contract award is a $14,293.80 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the supply of 4,565,546,815 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $42,881.40, is a delivery order to provide NEXPLANON 68 MG IMPLANTS. The contract has a firm fixed-price pricing type and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,293.80, is a delivery order issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA. The contract is for the delivery of 4,566,706,862 units of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product. The...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price contract is for the delivery of 4,564,449,404 NEXPLANON 68 MG IMPLANTS. This order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued up to $499,999,999, which runs through December 31, 2025. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the purchase of NEXPLANON 68 MG IMPLANTS, a contraceptive device. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
This federal contract award, valued at $4,288.14, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,185,173 units of the NEXPLANON 68 MG IMPLANTS pharmaceutical product. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,943.10 firm fixed-price delivery order is for the provision of 4,567,731,884 units of NEXPLANON 68 MG IMPLANTS. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. government awarded a Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,429.38 firm fixed-price contract is for the supply of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of the Defense Logistics Agency (DLA). This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of...
  • SPE2DB22D9247
    Indefinite Delivery Contract
  • SPE2DB22D9247-SPE2DB24FS2FJ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the supply of 4,565,254,941 NEXPLANON 68 MG IMPLANTS. This award is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation. Through this IDC and separate prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 10/23/24, 9:37 AM